BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27

• Pharm Country

  NovoCure Ltd. To Present Fifteen Abstracts Describing Latest Aspects Of NovoTTF™ Therapy At The 4th Quadrennial Meeting Of The World Federation Of Neuro-Oncology (WFNO)

  November 18, 2013

   · 

  5 min read
• Pharm Country

  Cancer Genetics, Inc. Announces U.S. Launch Of Its Proprietary DNA-Based Cervical Cancer Diagnostic Test, FHACT™

  November 18, 2013

   · 

  1 min read
• Genetown

  Aegerion Pharmaceuticals, Inc. Recognized As A “Top Place to Work” By The Boston Globe

  November 18, 2013

   · 

  1 min read
• Drug Development

  Catalyst Pharmaceutical Partners, Inc. Announces Publication Of Preclinical Proof-Of-Principle Of CPP-115 Efficacy in Suppressing Infantile Spasms In Epilepsia

  November 18, 2013

   · 

  1 min read
• Drug Development

  OXiGENE To Present Phase I Data Demonstrating Antitumor Activity Of OXi4503 In Patients With Acute Myeloid Leukemia And Myelodysplastic Syndromes

  November 18, 2013

   · 

  1 min read
• Bio NC

  Chelsea Therapeutics, Inc. Completes Public Offering Of Common Stock

  November 18, 2013

   · 

  1 min read
• BioMidwest

  Durata Therapeutics, Inc. to Present at the Jefferies 2013 Global Healthcare Conference

  November 18, 2013

   · 

  1 min read
• Genetown

  Agenus (Formerly known as Antigenics Inc. - New York)’ Brain Cancer Vaccine Program Named A “Top Project To Watch” By Elsevier Business Intelligence

  November 18, 2013

   · 

  1 min read
• Genetown

  SAGE Therapeutics’s Novel Approach To Treatment Of CNS Disorders To Be Highlighted At Leading Industry And Scientific Conferences

  November 18, 2013

   · 

  1 min read
• Pharm Country

  NanoViricides, Inc. Files Quarterly Report - Reports A Strong Cash Position Sufficient For Clinical Trials Of Its First Drug Candidate

  November 18, 2013

   · 

  1 min read